Uromigos Live 2024 Front-Line Therapy in Papillary RCC Part 1: SUNNIFORECAST Discussion

By Brian Rini, MD, FASCO, Thomas Powles, MBBS, MRCP, MD, Laurence Albiges, MD, PhD, David F. McDermott, MD, Hans Hammers, MD, PhD - Last Updated: October 30, 2024

At Uromigos Live 2024, a panel moderated by Brian Rini focused on the use of front-line therapy in papillary renal cancer and featured discussion on new and upcoming data in the field. The panel featured Tom Powles along with guests Laurence Albiges, MD, Institute Gustave-Roussy; David McDermott, MD, Beth Israel Deaconess Medical Center; and Hans Hammers, MD, UT Southwestern Medical Center.
In part one of the session, the panelists dive into an in-depth exploration and debate on the results of the SUNNIFORECAST study in nccRCC.

Advertisement

Advertisement
Advertisement
Advertisement